PROZAC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prozac, and when can generic versions of Prozac launch?
Prozac is a drug marketed by Eli Lilly And Co and Lilly and is included in four NDAs.
The generic ingredient in PROZAC is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prozac
A generic version of PROZAC was approved as fluoxetine hydrochloride by APNAR PHARMA LP on August 2nd, 2001.
Summary for PROZAC
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 174 |
Clinical Trials: | 110 |
Patent Applications: | 3,819 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PROZAC |
Drug Sales Revenues: | Drug sales revenues for PROZAC |
What excipients (inactive ingredients) are in PROZAC? | PROZAC excipients list |
DailyMed Link: | PROZAC at DailyMed |
Recent Clinical Trials for PROZAC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Avy L. & Roberta L. Miller Foundation | Phase 2 |
Stanford University | Phase 2 |
Milton S. Hershey Medical Center | Early Phase 1 |
Pharmacology for PROZAC
Drug Class | Serotonin Reuptake Inhibitor |
Mechanism of Action | Serotonin Uptake Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for PROZAC
US Patents and Regulatory Information for PROZAC
Expired US Patents for PROZAC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lilly | PROZAC | fluoxetine hydrochloride | SOLUTION;ORAL | 020101-001 | Apr 24, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Lilly | PROZAC | fluoxetine hydrochloride | SOLUTION;ORAL | 020101-001 | Apr 24, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Eli Lilly And Co | PROZAC | fluoxetine hydrochloride | CAPSULE;ORAL | 018936-001 | Dec 29, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Eli Lilly And Co | PROZAC | fluoxetine hydrochloride | CAPSULE;ORAL | 018936-001 | Dec 29, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Eli Lilly And Co | PROZAC | fluoxetine hydrochloride | CAPSULE;ORAL | 018936-006 | Dec 23, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Lilly | PROZAC | fluoxetine hydrochloride | SOLUTION;ORAL | 020101-001 | Apr 24, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROZAC
See the table below for patents covering PROZAC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Argentina | 205633 | UN PROCEDIMIENTO PARA PREPARAR COMPUESTOS DE 3-FENOXI-3-FENILPROPILAMINA | ⤷ Try a Trial |
Austria | 337161 | ⤷ Try a Trial | |
Poland | 101249 | ⤷ Try a Trial | |
Canada | 1051034 | ARYLOXYPHENYLPROPYLAMINES (ARYLOXYPHENYLPROPYLAMINES) | ⤷ Try a Trial |
Eurasian Patent Organization | 004539 | КОМБИНАЦИОННАЯ ТЕРАПИЯ ДЛЯ ЛЕЧЕНИЯ РЕЗИСТЕНТНОЙ ДЕПРЕССИИ (COMBINATION THERAPY FOR TREATMENT OF REFRACTORY DEPRESSION) | ⤷ Try a Trial |
Austria | 175358 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |